Aspect Medical Applies EEG Tech To Clinical Depression, Drug Research
This article was originally published in The Gray Sheet
The neuroscience division of Aspect Medical Systems expects late 2004 results of a Massachusetts General Hospital (MGH) trial studying the firm's quantitative EEG-based technology as a correlate of depression treatment outcomes will help support a clinical management indication
You may also be interested in...
Aspect Medical Systems intends to expand into the $300-$350 mil. market for emergency room and interventional radiology applications with the BIS XP Bispectral Index anesthesia monitoring technology platform within nine to 15 months, the firm says
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.